| ADP | Caption | 2026-09 cons. | 2026-06 cons. | 2026-03 cons. | 2025-12 cons. | 2025-09 cons. | 2025-06 cons. | 2025-03 cons. | >> 2024-12 cons. |
| 1 | I. CASH FLOW FROM OPERATING ACTIVITIES (ADP 2+18+35+36+37) | 65,149,719 | 4,985,519 |  |  |  |  |  |  |
| 2 | 1. Cash flow before changes in operating assets and liabilities (ADP 3+4) | 50,108,295 | 34,550,629 |  |  |  |  |  |  |
| 3 | 1.1. Profit/loss of the accounting period | 64,747,884 | 44,379,056 |  |  |  |  |  |  |
| 4 | 1.2. Adjustments (ADP 5+6+...+17) | -14,639,589 | -9,828,427 |  |  |  |  |  |  |
| 5 | 1.2.1. Depreciation of property and equipment | 9,704,014 | 6,497,305 |  |  |  |  |  |  |
| 6 | 1.2.2. Amortization of intangible assets | 3,648,003 | 2,287,913 |  |  |  |  |  |  |
| 7 | 1.2.3. Loss from impairment of intangible assets | 0 | 0 |  |  |  |  |  |  |
| 8 | 1.2.4. Other financial cost | 0 | 0 |  |  |  |  |  |  |
| 9 | 1.2.5. Impairment and gains/losses on fair valuation | -1,105,389 | 1,627,730 |  |  |  |  |  |  |
| 10 | 1.2.6. Interest expenses | 1,275,814 | 756,726 |  |  |  |  |  |  |
| 11 | 1.2.7. Interest income | -23,592,615 | -15,286,610 |  |  |  |  |  |  |
| 12 | 1.2.8. Profit from the sale of branch | 0 | 0 |  |  |  |  |  |  |
| 13 | 1.2.9. Share in profit of associates | -1,390,252 | -922,463 |  |  |  |  |  |  |
| 14 | 1.2.10. Equity-settled share-based payment transactions | 0 | 0 |  |  |  |  |  |  |
| 15 | 1.2.11. Cost of income tax | 10,681,241 | 7,272,055 |  |  |  |  |  |  |
| 16 | 1.2.12. Profit/loss from the sale of tangible assets (including land and buildings) | 357,863 | -173,470 |  |  |  |  |  |  |
| 17 | 1.2.13. Other adjustments | -14,218,268 | -11,887,613 |  |  |  |  |  |  |
| 18 | 2. Increase/decrease in operating assets and liabilities (ADP 19+20+...+34) | -12,821,701 | -51,128,424 |  |  |  |  |  |  |
| 19 | 2.1. Increase/decrease in financial assets at fair value through other comprehensive income | -113,974,048 | -75,590,660 |  |  |  |  |  |  |
| 20 | 2.2. Increase/decrease in financial assets at fair value through statement of profit or loss | -19,769,207 | -75,019,425 |  |  |  |  |  |  |
| 21 | 2.3. Increase/decrease in financial assets at amortised cost | 97,943,483 | 90,015,613 |  |  |  |  |  |  |
| 22 | 2.4. Increase/decrease in assets/liabilities from insurance contracts | 38,676,263 | 23,373,090 |  |  |  |  |  |  |
| 23 | 2.5. Increase/decrease in assets/liabilities from reinsurance contracts | 3,036,082 | 6,715,808 |  |  |  |  |  |  |
| 24 | 2.6. Increase/decrease in tax assets | -3,576,491 | -496,592 |  |  |  |  |  |  |
| 25 | 2.7. Increase/decrease in receivables | 0 | 0 |  |  |  |  |  |  |
| 26 | 2.8. Increase/decrease in investments in real estate | -4,828,184 | -4,094,409 |  |  |  |  |  |  |
| 27 | 2.9. Increase/decrease in property for own use | 0 | 0 |  |  |  |  |  |  |
| 28 | 2.10. Increase/decrease in other assets | -10,207,874 | -4,704,613 |  |  |  |  |  |  |
| 29 | 2.11. Increase/decrease in liabilities from investment contracts | 0 | 0 |  |  |  |  |  |  |
| 30 | 2.12. Increase/decrease in other provisions | -580,078 | -750,211 |  |  |  |  |  |  |
| 31 | 2.13. Increase/decrease in tax liabilities | 2,895,410 | -4,817 |  |  |  |  |  |  |
| 32 | 2.14. Increase/decrease in financial liabilities | 11,234,869 | 791,001 |  |  |  |  |  |  |
| 33 | 2.15. Increase/decrease in other liabilities | -11,570,848 | -10,320,182 |  |  |  |  |  |  |
| 34 | 2.16. Increase/decrease in accruals and deferred income | -2,101,078 | -1,043,027 |  |  |  |  |  |  |
| 35 | 3. Income tax paid | -10,145,354 | -7,164,482 |  |  |  |  |  |  |
| 36 | 4. Interest received | 23,233,189 | 16,276,039 |  |  |  |  |  |  |
| 37 | 5. Dividend received | 14,775,290 | 12,451,757 |  |  |  |  |  |  |
| 38 | II. CASH FLOW FROM INVESTING ACTIVITIES (ADP 39+40+...+45) | -10,108,266 | -6,094,485 |  |  |  |  |  |  |
| 39 | 1. Cash receipts from the sale of tangible assets | 646,688 | 519,761 |  |  |  |  |  |  |
| 40 | 2. Cash payments for the purchase of tangible assets | -5,791,346 | -3,955,023 |  |  |  |  |  |  |
| 41 | 3. Cash receipts from the sale of intangible assets | 36 | 0 |  |  |  |  |  |  |
| 42 | 4. Cash payments for the purchase of intangible assets | -4,963,644 | -2,659,223 |  |  |  |  |  |  |
| 43 | 5. Cash receipts from the sale of branches, associates and joint ventures | 0 | 0 |  |  |  |  |  |  |
| 44 | 6. Cash payments for the purchase of branches, associates and joint ventures | 0 | 0 |  |  |  |  |  |  |
| 45 | 7. Cash receipts and payments based on other investing activities | 0 | 0 |  |  |  |  |  |  |
| 46 | III. CASH FLOW FROM FINANCING ACTIVITIES (ADP 47+48+...+57) | -53,741,378 | -3,114,374 |  |  |  |  |  |  |
| 47 | 1. Cash receipts resulting from the increase of initial capital | 0 | 0 |  |  |  |  |  |  |
| 48 | 2. Cash receipts from issuing redeemable preference shares | 0 | 0 |  |  |  |  |  |  |
| 49 | 3. Cash receipts from short-term and long-term loans received | 0 | 0 |  |  |  |  |  |  |
| 50 | 4. Cash receipts from sales of own shares | 0 | 0 |  |  |  |  |  |  |
| 51 | 5. Cash receipts from exercise of share options | 0 | 0 |  |  |  |  |  |  |
| 52 | 6. Cash payments relating to redeemable preference shares | 0 | 0 |  |  |  |  |  |  |
| 53 | 7. Cash payments for the repayment of short-term and long-term loans received | -265,230 | -176,778 |  |  |  |  |  |  |
| 54 | 8. Cash payments for the redemption of own shares | 0 | 0 |  |  |  |  |  |  |
| 55 | 9. Cash payments for interest | -37,931 | -25,461 |  |  |  |  |  |  |
| 56 | 10. Cash payments for dividend | -49,067,630 | 0 |  |  |  |  |  |  |
| 57 | 11. Cash payments for rental obligations | -4,370,587 | -2,912,135 |  |  |  |  |  |  |
| 58 | IV. NET CASH FLOW (ADP 1+38+46) | 1,300,075 | -4,223,340 |  |  |  |  |  |  |
| 59 | V. EFFECT OF EXCHANGE RATE FLUCTUATIONS ON CASH AND CASH EQUIVALENTS | 13,166 | 12,839 |  |  |  |  |  |  |
| 60 | VI. NET INCREASE/DECREASE OF CASH AND CASH EQUIVALENTS (ADP 58+59) | 1,313,241 | -4,210,501 |  |  |  |  |  |  |
| 61 | 1. Cash and cash equivalents at the beginning of period | 16,347,575 | 16,347,575 |  |  |  |  |  |  |
| 62 | 2. Cash and cash equivalents at the end of period (ADP 60+61) | 17,660,816 | 12,137,074 |  |  |  |  |  |  |